Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-22

  1. 5,514 Posts.
    lightbulb Created with Sketch. 684
    Potential here is greater than IMU in my opinion ($700m + market cap $1.15) in a few years.

    This was a left field announcement, we are all expecting a deal for phase 2 with AD 214 IPF lung hopefully with an upfront payment greater than US$45m and milestone payments . We get that this goes over 20c in my opinion

    The EV should significantly increase once market digests today’s news . Hopefully Wednesday Webinar is well received with smart money.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $3.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $0 118

Buyers (Bids)

No. Vol. Price($)
23 25982277 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 13641802 16
View Market Depth
Last trade - 13.19pm 07/08/2025 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.